OUR STORY
Our Vision
2022-11-30 08:00:00
Our vision is to be a leader in identifying, developing and commercializing novel drugs that address unmet needs of people with rare cancer conditions.
Learn more about us:
Ascelia Pharma FDA and SPARKLE Update December 2022 (PDF)
Webcast Pressrelease December 2022
Q3-2022 Investor Conference Call
Ascelia Pharma Company Presentation December 2022
Upcoming Events
Latest News
Presentations & Articles
INVESTOR